Abstract
A 70-kDaPlasmodium falciparum exoantigen was purified from supernatant fluids of continuous in vitroP. falciparum cultures using sequential cation-exchange and high performance liquid chromatographic procedures. The purified protein was then digested with chymotrypsin and amino-acid sequences were determined for the resulting fragments. Four peptides (termed C2, C3, C5, and C10) were subsequently selected for synthesis based on their predictability for antigenic sites. The peptides were effectively used as a synthetic immunogen (SPf70) when they had been copolymerized with glutaraldehyde in the absence of a carrier. When given with Freund's adjuvant, the synthetic peptide complex was found to be highly immunogenic in rabbits. Serologic reactivity to the peptide complex and peptides C2 and C5 was uniformly high, followed by the responses to peptides C3 and C10. Peptide antigenicity was also assessed with human anti-P. falciparum sera from malaria-endemic regions of Uganda and Venezuela. Enzymelinked immunosorbent assay (ELISA) data showed that anti-P. falciparum antibodies were specific for and reactive to the peptides. The specificity of the rabbit anti-SPf70 antibodies forP. falciparum antigen was shown by immunoprecipitation of metabolically labeled proteins and by immunoblotting. Herein we describe the peptide sequences of a 70-kDaP. falciparum exoantigen (Pf70) that, when synthesized and constructed as a copolymer (SPf70), are capable of inducing the formation of antibodies that are reactive with the native malarial protein. The high immunogenicity and antigenic reactivity of SPf70 indicate the potential use of this synthetic peptide polymer as an immunogen and a diagnostic reagent.
Similar content being viewed by others
References
Baird JK, Jones TR, Danudirgo EW, Annis BA, Bangs MJ, Basri H, Purnomo, Masbar S (1991). Age-dependent acquired protection againstPlasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg 45:65–76
Bate CAW, Taverne J, Davé A, Playfair JHL (1990) Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology 70:315–320
Berzofsky JA (1991) Mechanisms of T cell recognition with application to vaccine design. Mol Immunol 28:217–223
Braun-Breton C, Jendoubi M, Brunet E, Perrin L, Scaife J, DaSilva LP (1986) In vivo time course of synthesis and processing of major schizont polypeptides inPlasmodium falciparum. Mol Biochem Parasitol 20:33–43
Briand JP, Muller S, Van Regenmortel MHV (1985) Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods 78:59–69
Chou PY, Fasman G (1974) Prediction of protein conformation. Biochemistry 13:222–245
Good MF, Miller LH (1990) T-cell antigens and epitopes in malaria vaccine design. Curr Top Microbiol Immunol 155:65–78
Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert P-H (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320:1586–1591
Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78:3824–3828
James MA, Kakoma I, Ristic M, Cagnard M (1985) Induction of protective immunity toPlasmodium falciparum inSaimiri sciureus monkeys with partially purified exoantigens. Infect Immun 49:476–480
Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN (1992) Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms inPlasmodium vivax malaria. Proc Natl Acad Sci USA 89:3200–3203
Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM (1989) Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 77:361–366
Kwiatkowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicatedPlasmodium falciparum malaria. Lancet 336:1201–1204
Kyte J, Doolittle R (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105–132
Leclerc C, Przewlocki G, Schutze M-P, Chedid L (1987) A synthetic vaccine constructed by copolymerization of B and T cell determinants. Eur J Immunol 17:269–273
Mendis KN (1992) Contrasting clinical disease inPlasmodium vivax andPlasmodium falciparum malaria, and the association of both with cytokines. Bull Inst Pasteur 90:3–9
Merrifield RB (1963) Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85:2149–2154
Molyneux M (1990) Cerebral malaria in children: clinical implications of cytoadherence. Am J Trop Med Hyg 43 [Suppl]:38–41
Playfair JHL, Taverne J, Bate CAW, Souza JB de (1990) The malaria vaccine: anti-parasite or anti-disease? Immunol Today 11:25–27
Playfair JHL, Taverne J, Bate CAW (1991) Don't kill the parasite: control the disease. Acta Leiden 60:157–165
Ribeiro C, Deslandes D, Ferreira-da-Cruz MF, Oliveira-Ferreira J, Druilhe P (1991) Study of the humoral response against three definedP. falciparum antigens in different populations using synthetic peptides and an immunoenzymatic assay. Proc IV Intl Cong Malaria and Babesiosis, Rio de Janeiro, Abstr. 2.22
Scuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Peterson E, Slymen DJ, Salmon SE (1986) Raised serum levels of TNF in parasitic infections. Lancet II:1364–1365
Shamansky LM (1986) Purification and characterization of soluble antigens from the human malaria parasitePlasmodium falciparum. Ph D Thesis, University of Illinois, Urbana-Champaign, Illinois
Shamansky LM, Liu H, Hager LP, Ristic M (1985) Purification and characterization of culture-derived exoantigens ofPlasmodium falciparum. Mol Biochem Parasitol 17:299–310
Stone KL, Elliott JI, Peterson G, McMurray W, Williams KR (1990a) Reversed-phase high-performance liquid chromatography for fractionation of enzymatic digests and chemical cleavage products of proteins. Methods Enzymol 193:389–412
Stone KL, Lo Presti MB, Williams KR (1990b) Enzymatic digestion of proteins and HPLC peptide isolation in the sub-nanomole range. In: Fini C, Floridi A, Finelli VN (eds) Laboratory methodology in biochemistry. CRC, Boca Raton, pp 181–205
Taverne J, Bate CAW, Kwiatkowski D, Jakobsen PH, Playfair JHL (1990a) Two soluble antigens ofPlasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun 58:2923–2928
Taverne J, Bate CAW, Sarkar DA, Meager A, Rook GAW, Playfair JHL (1990b) Human and murine macrophages produce TNF in response to soluble antigens ofPlasmodium falciparum. Parasite Immunol 12:33–43
Thelu J, Ambroise-Thomas P, Chumpitazi B, Kupka P (1985) Purification and immunochemical study ofPlasmodium falciparum exoantigens. J Parasitol 71:542–546
Toebe CS, Montenegro-James S, Noya O, Riggione F, James MA (1993) Detection of antibodies to a 70 kDaPlasmodium falciparum exoantigen in malarious subjects using synthetic peptides. Trop Med Parasitol 44:1–4
Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193:673–675
Wilson RJM, McGregor IA, Hall P, Williams K, Bartholomew R (1969) Antigens associated withPlasmodium falciparum infections in man. Lancet II:201–205
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
James, M.A., Montenegro-James, S. & Fajfar-Whetstone, C. Immunogenicity and antigenic reactivity of a carrier-free synthetic peptide complex derived from a 70-kDaPlasmodium falciparum exoantigen. Parasitol Res 79, 501–507 (1993). https://doi.org/10.1007/BF00931592
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00931592